🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

26+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

ℹ
Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 6 of 26 recruiting trials for “Acute myeloid leukemia with 11q23 abnormalities”

Phase 1, PHASE2RecruitingNCT04128748 ↗

Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome

👨‍⚕️ Musa Yilmaz, M.D. Anderson Cancer Center📍 1 site📅 Started May 2020View details ↗
Phase 1, PHASE2RecruitingNCT04065399 ↗

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

👨‍⚕️ Angela R Smith, M.D., Syndax Pharmaceuticals📍 57 sites📅 Started Nov 2019View details ↗
Phase 1, PHASE2RecruitingNCT04067336 ↗

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

🏥 Kura Oncology, Inc.📍 56 sites📅 Started Sep 2019View details ↗
Phase 1, PHASE2RecruitingNCT04068597 ↗

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

👨‍⚕️ Tim Somervaille, The Christie NHS Foundation Trust📍 39 sites📅 Started Aug 2019View details ↗
Phase 1RecruitingNCT03802695 ↗

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

👨‍⚕️ James S McClellan, MD, PhD, Orca Biosystems, Inc.📍 9 sites📅 Started Apr 2019View details ↗
Phase 2RecruitingNCT03586609 ↗

Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia

👨‍⚕️ Tapan M Kadia, M.D. Anderson Cancer Center📍 1 site📅 Started Oct 2018View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →